FMS News and Press, Fresenius Medical Care AG

2026-02-24 15:47:53 ET Fresenius Medical Care AG (FMS) Q4 2025 Earnings Call February 24, 2026 8:00 AM EST... Read the full article on Seeking Alpha For further details see: Fresenius Medical Care AG (FMS) Q4 2025 Earnings Call Transcript

Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band PR Newswire Strong organic revenue growth 1 in 2025 of 8% driven by all operating segments Driven by an exceptional Q4, full year op...

Interface Inc. (TILE) is expected to report $0.4 for Q4 2025 Evolent Health Inc Class A (EVH) is expected to report $-0.03 for Q4 2025 MercadoLibre Inc. (MELI) is expected to report $11.77 for Q4 2025 Clean Energy Fuels Corp. (CLNE) is expected to report $-0.1 for Q4 2025 Kiniksa ...

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an) (FMS) is expected to report $0.67 for Q4 2025

2026-02-24 01:23:47 ET More on Fresenius Medical Care Fresenius Medical Care: Low Confidence On Growth Acceleration Limits Upside Fresenius Medical Care AG (FMS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Fresenius Medical Care Q4 2025 Earni...

2026-02-23 10:09:59 ET More on Fresenius Medical Care Fresenius Medical Care: Low Confidence On Growth Acceleration Limits Upside Fresenius Medical Care AG (FMS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Fresenius Medical Care: 'Buy' Again ...

2026-02-03 14:09:46 ET More on DaVita, Berkshire Hathaway Inc. DaVita: Some Success Is Possible, But Volatility Is Still Heavy Berkshire Hathaway: I'm More Bullish Than Ever DaVita Inc. (DVA) Q4 2025 Earnings Call Transcript DaVita outlines 33% EPS growth tar...

2026-02-03 10:30:39 ET You may recall my previous article on Davita ( DVA ), when I initiated coverage and called this company a volatile "BUY", but one with a higher upside than peers. Those peers include one of my favorite investments in the entire sector, Fresenius ( FSNUY ...

2026-01-29 18:16:53 ET Despite well over 20 years of free cash flow growth, Fresenius Medical Care ( FMS ) shares have gone basically nowhere in the last 15 years on a net basis, and have only appreciated a little more than 3% a year since 2005. This is a case in point as to why low-gro...

2026-01-20 04:15:07 ET Goldman Sachs analyst issues NEUTRAL recommendation for FMS on January 20, 2026 09:24AM ET. FMS was trading at $21.95 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 5 - Buy, 12 - ...